Biotech · Private company
Camurus AB
Track this companyFree. Adds Camurus AB to your Dealase workspace and tells you when its record changes.
Clinical trials52 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- CAM2029Phase 3 · Gastro-enteropancreatic Neuroendocrine TumorClinicalTrials.gov · fetched Nov 12, 2026
- CAM2029Phase 3 · Polycystic Liver DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- CAM2029 (octreotide subcutaneous depot)Phase 3 · AcromegalyClinicalTrials.gov · fetched Nov 12, 2026
- Lanreotide ATGPhase 3 · Gastro-enteropancreatic Neuroendocrine TumorClinicalTrials.gov · fetched Nov 12, 2026
- Octreotide LARPhase 3 · Gastro-enteropancreatic Neuroendocrine TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLDPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Jun 28, 2022ClinicalTrials.gov NCT05281328 · fetched Nov 12, 2026
- A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NETPHASE3 · ACTIVE_NOT_RECRUITING · started Oct 22, 2021ClinicalTrials.gov NCT05050942 · fetched Nov 12, 2026
- A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With AcromegalyPHASE3 · COMPLETED · started Oct 10, 2019ClinicalTrials.gov NCT04125836 · fetched Nov 12, 2026
- A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With AcromegalyPHASE3 · COMPLETED · started Aug 19, 2019ClinicalTrials.gov NCT04076462 · fetched Nov 12, 2026
- Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back PainPHASE3 · COMPLETED · started Sep 1, 2016ClinicalTrials.gov NCT02946073 · fetched Nov 12, 2026